Table 1 Baseline characteristics of patients who underwent percutaneous coronary intervention with drug-eluting balloons

Patients (n)

362

261

101

101

65

36

261

196

65

eGFR (ml/min/1.73²)

73.2 ± 27.1

86.1 ± 17.4

40.2 ± 17.9

70.2 ±  27.5

86.5 ± 16.4

40.7 ± 17.2

< 0.001

74.5 ±  26.8

86.0 ± 17.8

39.9 ± 18.4

< 0.001

Men (%)

291 (80.4%)

219 (83.9%)

72 (71.3%)

75 (74.3%)

51 (78.5%)

24 (66.7%)

0.2

216 (82.8%)

168 (85.7%)

48 (73.9%)

< 0.05

Age (years)

66.4 ± 11.4

64.0 ± 10.8

72.5 ± 10.8

67.4 ± 10.9

64.0 ± 9.7

73.5 ± 10.2

< 0.001

66.0 ± 11.6

64.0 ± 11.2

71.9 ± 11.1

0.001

BMI (%)

28.6 ± 4.5

28.4 ± 4.5

28.9 ± 4.5

27.7 ± 4.0

27.8 ± 4.1

27.6 ± 3.7

0.8

28.9 ± 4.6

28.6 ± 4.6

29.7 ± 4.8

0.1

 Smoker (%)

140 (38.7%)

112 (42.9%)

28 (27.7%)

38 (37.6%)

27 (41.5%)

11 (30.6%)

0.3

102 (39.1%)

85 (43.4%)

17 (26.2%)

< 0.05

 Diabetes mellitus (%)

166 (45.9%)

105 (40.2%)

61 (60.4%)

55 (54.5%)

31 (47.7%)

24 (66.7%)

0.1

111 (42.5%)

74 (37.8%)

37 (56.9%)

< 0.01

 COPD (%)

22 (6.1%)

11 (4.2%)

11 (10.9%)

5 (5.0%)

3 (4.6%)

2 (5.6%)

1

17 (6.5%)

8 (4.1%)

9 (13.9%)

< 0.05

 Hyperlipidemia (%)

259 (71.6%)

191 (73.2%)

68 (67.3%)

79 (78.2%)

53 (81.5%)

26 (72.2%)

0.3

180 (69.0%)

138 (70.4%)

42 (64.6%)

0.4

 Hypertension (%)

263 (72.8%)

173 (66.5%)

90 (89.1%)

77 (76.2%)

47 (72.3%)

30 (83.3%)

0.2

186 (71.5%)

126 (64.6%)

60 (92.3%)

< 0.001

 ACS (%)

139 (38.4%)

92 (35.3%)

47 (46.5%)

35 (34.7%)

19 (29.2%)

16 (44.4%)

0.1

104 (39.9%)

73 (37.2%)

31 (47.7%)

0.2

 CHF (%)

18 (5.0%)

4 (1.5%)

14 (13.9%)

10 (9.9%)

2 (3.1%)

8 (22.2%)

< 0.005

8 (3.1%)

2 (1.0%)

6 (9.2%)

< 0.005

 EF (%)

48.2 ± 8.8

49.4 ± 8.0

45.0 ± 10.0

45.7 ± 9.3

47.5 ± 8.6

42.6 ± 9.9

< 0.05

49.1 ± 8.4

50.0 ± 7.7

46.4 ± 9.8

< 0.01